Download PDF
Thromb Haemost 1992; 68(02): 102-105
DOI: 10.1055/s-0038-1656331
Original Article
Schattauer GmbH Stuttgart

Peritoneal Fluid and Plasma Fibrinolytic Activity in Women with Pelvic Inflammatory Disease

P J Dörr
1   The Department of Obstetrics and Gynecology, Westeinde Hospital, The Hague, The Netherlands
,
E J P Brommer
2   The Gaubius Laboratory-IVVO, Health Research Division TNO, Leiden, The Netherlands
,
G Dooijewaard
2   The Gaubius Laboratory-IVVO, Health Research Division TNO, Leiden, The Netherlands
,
H M Vemer
3   The Department of Obstetrics and Gynecology, University Hospital, Nijmegen, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 12 December 1991

Accepted after revision 26 February 1992

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Previous studies have shown that the fibrinolytic activity of peritoneum is depressed in local inflammation. We measured fibrinolytic parameters in peritoneal fluid and in plasma of 10 women with pelvic inflammatory disease (PID). Nine women, in whom laparoscopy for sterilisation was performed, served as a control group.

In the peritoneal fluid of women with PID, PAI-Ag, t-PA-Ag and u-PA-Ag were many times higher than in the control group. In contrast to the antigens which may be present in inert complexes, the potentially active compounds, measured as t-PA activity and plasmin-activable scu-PA, were not significantly different in the two groups, and in none of the samples was the active enzyme tcu-PA detectable. Nevertheless, the mean peritoneal fluid TDP and FbDP concentrations were about twenty times higher in the PID group than in the control group. In plasma of PID patients, none of the parameters except u-PA-Ag differed from those in the control group. The difference between control and patient plasma u-PA-Ag was statistically significant, but too small to attach any relevance to the observation.

Our data suggest that, in contrast to the classical concept of decreased fibrinolytic activity as a cause of adhesion formation, intraperitoneal fibrinolysis is enhanced in peritoneal inflammation through stimulation of the local production of t-PA and u-PA. Despite concomitant production of PAI, fibrinolysis occurs at a high rate, resulting in high levels of fibrin degradation products. Since this activated fibrinolysis does not meet the demand, therapeutic enhancement should be considered to prevent adhesions.

 

  • References

  • 1 Weström L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138: 880-892
    CrossrefPubMedGoogle Scholar
  • 2 Heinonen PK, Teisala K, Punnonen R, Miettenen A, Lehtinen M, Pavoonen J. Anatomic sites of upper genital tract infection. Obstet Gynecol 1985; 66: 384-390
    PubMedGoogle Scholar
  • 3 Centers for Disease Control Pelvic inflammatory disease: United States. MMWR 1980 28. 605-607
    PubMedGoogle Scholar
  • 4 World Health Organisation Non gonococcal urethritis and other sexually transmitted diseases of public health importance. WHO Tech RepSer 1981 660. 98-100
    PubMedGoogle Scholar
  • 5 Brosens IA, Gordon AG. The abnormal fallopian tube. In: Tubal Infertility. Gower Medical Publishing; London: 1989: 2.2-2.33
    Google Scholar
  • 6 Woodruff JD, Pauerstein CJ. The Fallopian Tube. Structure, Function, Pathology and Management. The Williams and Wilkins Co.; Baltimore, MD: 1969
    Google Scholar
  • 7 Weström L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121: 707-713
    CrossrefPubMedGoogle Scholar
  • 8 Ellis H, Harrison W, Hugh TB. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52: 471-476
    CrossrefPubMedGoogle Scholar
  • 9 Myhre-Jensen O, Bergman-Larsen S, Astrup T. Fibrinolytic activity in serosal and synovial membranes. Arch Pathol 1969; 88: 623-630
    PubMedGoogle Scholar
  • 10 Porter JM, Mc Gregor Jr F, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 80-82
    PubMedGoogle Scholar
  • 11 Hau T, Payne WD, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979; 148: 415-418
    PubMedGoogle Scholar
  • 12 Jacobson L, Weström L. Objectivized diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1969; 1088-1098
    PubMedGoogle Scholar
  • 13 Wølner-Hanssen P, Mårdh PE, Svensson L, Weström L. Laparoscopy in women with chlamydial infection and pelvic pain: A comparison with and without salpingitis. Obstet Gynecol 1983; 61: 299-303
    PubMedGoogle Scholar
  • 14 Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61: 113-114
    PubMedGoogle Scholar
  • 15 Vemer HM, Colla P, Schoot DC, Willemsen WNP, Bierkens PB, Rolland R. Women regretting their sterilization. Fertil Steril 1986; 46: 724-726
    CrossrefPubMedGoogle Scholar
  • 16 Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; 1: 153-156
    CrossrefPubMedGoogle Scholar
  • 17 Kirchheimer J, Binder BR. Urokinase antigen in plasma: age and sex dependent variations. Thromb Res 1984; 36: 643-646
    CrossrefPubMedGoogle Scholar
  • 18 Verheijen JH, Chang CTG, Kluft C. Evidence for the occurrence of a fast acting inhibitor of tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
    PubMedGoogle Scholar
  • 19 Binnema D, Van Iersel JJL, Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 1986; 43: 569-577
    CrossrefPubMedGoogle Scholar
  • 20 Hinsbergh v VWM, Berg vd EA, Fiers W, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990; 75: 1991-1998
    PubMedGoogle Scholar
  • 21 Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodki E, Dudley HAF. Reduced human plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384
    CrossrefPubMedGoogle Scholar
  • 22 Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335: 1120-1122
    CrossrefPubMedGoogle Scholar
  • 23 Ellis H. The aetiology of post-operative abdominal adhesions. An experimental study. Br J Surg 1962; 50: 10-16
    PubMedGoogle Scholar
  • 24 Ryan GB, Grobety J, Majno G. Postoperative peritoneal adhesions. A study of the mechanisms. Am J Pathol 1971; 65: 117-140
    PubMedGoogle Scholar
  • 25 Colucci M, Paramo JA, Stasse JM, Collen D. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components. J Clin Invest 1986; 78: 138-144
    PubMedGoogle Scholar
  • 26 Kooistra T, Bosma PJ, Jespersen J, Kluft C. Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables. Am J Obstet Gynecol 1990; 163: 404-412
    CrossrefPubMedGoogle Scholar
  • 27 Hinsberg v VWM, Kooistra T, Scheffer MA, Bockel v JH, Muijen v GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-1497
    PubMedGoogle Scholar
  • 28 Grøndahl-Hansen KirkebyLT, Ralfkiaer E, Kristensen P, Lund LR, Danø K. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am J Pathol 1989; 135: 631-636
    PubMedGoogle Scholar
  • 29 de Bruin PAF, Crama-Bohbouth G, Verspaeget HW, Verheijen JH, Dooijewaard G, Weterman IT, Lamers CBHW. Plasminogen activators in the intestine of patients with inflammatory bowel disease. Thromb Haemostas 1988; 60: 262-266
    PubMedGoogle Scholar
  • 30 Brommer EJP, Dooijewaard G, Dijkmans BAC, Breedveld FC. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Submitted for publication
    PubMedGoogle Scholar
  • 31 Albrechtsen OK. The fibrinolytic activity of human tissues. Br J Haematol 1957; 3: 284-291
    CrossrefPubMedGoogle Scholar
  • 32 Astrup T, Beller FK, Glas P, Rasmussen J. Fibrinolytic activity of the human uterine tube. Obstet Gynecol 1965; 25: 853-857
    PubMedGoogle Scholar
  • 33 Buckman RF, Woods M, Sargent L, Gervin AS. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976; 20: 1-5
    CrossrefPubMedGoogle Scholar
  • 34 Raftery AT. Regeneration of peritoneum: A fibrinolytic study. J Anat 1979; 3: 659-664
    PubMedGoogle Scholar
  • 35 Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in the rat. Eur Surg Res 1981; 13: 397-401
    PubMedGoogle Scholar
  • 36 Menziez D, Ellis H. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator. J R Soc Med 1989; 82: 534-535
    CrossrefPubMedGoogle Scholar
  • 37 McRitchie DI, Cummings D, Rotstein OD. Delayed administration of tissue plasminogen activator reduces intra-abdominal abscess formation. Arch Surg 1989; 124: 1406-1410
    CrossrefPubMedGoogle Scholar
  • 38 Dörr PJ, Vemer HM, Brommer EJP, Willemsen WNP, Veldhuizen RW, Rolland R. Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit. Eur J Obstet Gynecol Reprod Biol 1990; 37: 287-291
    CrossrefPubMedGoogle Scholar